Ultra Nasdaq Biotechnology Proshares (BIB) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US ETFDetailed Quotes

BIB Ultra Nasdaq Biotechnology Proshares

Watchlist

59.530
-0.120-0.20%

Close Nov 29 13:00 ET

59.990High59.500Low

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Wednesday Ends With Index Decline | Wall Street Today
Kevin TraversNov 27 16:08 ET
RBC Capital Maintains Outperform on Amgen, Lowers Price Target to $330
BenzingaNov 27 12:02 ET · Ratings
Amgen Analyst Ratings
BenzingaNov 27 12:01 ET · Ratings
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Kevin TraversNov 27 09:57 ET
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
Seeking AlphaNov 27 06:23 ET
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Kevin TraversNov 26 16:12 ET

Comments

KellyNg9

Jan 18 03:29

$SPDR S&P Biotech ETF (XBI.US)$ $Ultra Nasdaq Biotechnology Proshares (BIB.US)$ $iShares Biotechnology ETF (IBB.US)$
moomoo.com/cour...

Invest With Cici

Jan 18 02:07

Do you have a bullish outlook on the biotech sector for 2024? Feel free to share and discuss in the comments below.🥰 $SPDR S&P Biotech ETF (XBI.US)$ $Ultra Nasdaq Biotechnology Proshares (BIB.US)$ $iShares Biotechnology ETF (IBB.US)$

Guide to biotech investing

Meltyy

Aug 25, 2022 01:54

Health Care Sector Update for 08/24/2022: SPRC,GKOS,BCDA

$Ultra Nasdaq Biotechnology Proshares (BIB.US)$ was climbing 1.5%.
$SciSparc (SPRC.US)$ rallied Wednesday, climbing over 20%, after the Israeli pharmaceuticals company said the psychedelic-based MEAI drug candidate developed with Canadian collaborator Clearmind Medicine produced a significant decrease in coccaine craving in rats compared to those in a non-treated control group during pre-clinical testing.
$Glaukos (GKOS.US)$ gained 6% after We...